Pharmacological approaches to coronary microvascular dysfunction

This publication has 241 references indexed in Scilit:

• Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: Results from an international multicentre retrospective cohort study
  International Journal of Cardiology, 2013
• Targeting NADPH oxidases in vascular pharmacology
  Vascular Pharmacology, 2012
• High Prevalence of a Pathological Response to Acetylcholine Testing in Patients With Stable Angina Pectoris and Unobstructed Coronary Arteries
  JACC, 2012
• In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)
  American Heart Journal, 2011
• Microvascular Angina and the Continuing Dilemma of Chest Pain With Normal Coronary Angiograms
  JACC, 2009
• Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography
  JAMA, 2008
• Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy
  Free Radical Biology and Medicine, 2007
• Endothelial dysfunction in diabetes
  British Journal of Pharmacology, 2000
• Antioxidant status in patients with uncomplicated insulin‐dependent and non‐insulin‐dependent diabetes mellitus
  European Journal of Clinical Investigation, 1997
• Usefulness of changes in exercise tolerance induced by nitroglycerin in identifying patients with syndrome X
  American Heart Journal, 1994